L-homocysteine (CED0001137)

Record Information
Version1.0
Creation Date2026-04-05 19:18:39 UTC
Update Date2026-04-05 19:18:39 UTC
SynCED IDCED0001137
Secondary Accession Numbers
  • CHEM106818
Identification
Common NameL-homocysteine
ClassSmall Molecule
Description
L-homocysteine is an organic compound with the formula C4H9NO2S. L-homocysteine belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. This substance is found in or released from one recorded source: electrical and electronic equipment, specifically antennas.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC4H9NO2S
Average Molecular MassNot Available
Monoisotopic Mass135.035 g/mol
CAS Registry NumberNot Available
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)
InChI KeyFFFHZYDWPBMWHY-VKHMYHEASA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
GC-MSGC-MS Spectrumsplash10-004i-0920000000-20fbffbe76510c066e6fNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0006-9000000000-1f800d28bca4b2b7a49fNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014l-4900000000-c50d79ba3a5013bcf29fNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-000i-9000000000-025c9e1f4fb58138c43bNot AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-014i-4900000000-33f205e002f49f034764Not AvailableView Spectrum
LC-MS/MSLC-MS/MS Spectrumsplash10-052r-0900000000-c1f98c8182b5ddc09cb1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00ko-9800000000-80a1c80328e8836233a4Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-9100000000-1f611da44349ffdfaefeNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0bvi-9000000000-c9d62a66522e46a17f56Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-3900000000-e8322d5858cba16a3bd2Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00lr-6900000000-e0190a1cc33e605bac0aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-9000000000-900bb5d8fb11bec02e39Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-0900000000-38e427e24202b2411597Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-7900000000-5cf2133d9faac56032d3Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-9000000000-942ac689538269d6ca7bNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-9000000000-166428542631f9ac0714Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4i-9000000000-9bcb57b924579a6c3411Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4j-9000000000-8eee886864db64f3eec2Not AvailableView Spectrum
1D NMR1H NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
1D NMR13C NMR Spectrum (1D, D2O, predicted)Not AvailableNot AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
2033.0 Log mg/kg [1100:3600]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
hypertensionAssociated With?increaseA disorder characterized by a pathological increase in blood pressure; a repeatedly elevation in the blood pressure exceeding 140 over 90 mm Hg. (NCI CTCAE)PMC8031033
hypertensionAssociated With?Not AvailableA disorder characterized by a pathological increase in blood pressure; a repeatedly elevation in the blood pressure exceeding 140 over 90 mm Hg. (NCI CTCAE)PMC3460365
inflammationAssociated With?increaseNot AvailablePMC7337253 , PMC12691759
inflammationAssociated With?Not AvailableNot AvailablePMC13066785
cancerAssociated With?increaseCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC8638980
cancerElevated in Blood InincreaseCancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. There are over 100 types of cancers affect humans. The risk of developing certain cancers can be reduced by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. The majority of cancers, some 90–95% of cases, are due to genetic mutations from environmental and lifestyle factors. The remaining 5–10% are due to inherited genetics.PMC10385089
Alzheimer's diseaseAssociated With?increaseA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC9414574 , PMC12652985
Alzheimer's diseaseElevated in Blood InincreaseA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC12331690
Alzheimer's diseaseAssociated With?Not AvailableA neurodegenerative disease which causes neural atrophy, leading to dementia and memory loss.PMC11367486 , PMC10305463
dementiaAssociated With?increaseA cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior. (DO)PMC8868221
dementiaAssociated With?Not AvailableA cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior. (DO)PMC3506942
anemiaAssociated With?increaseA disorder characterized by a reduction in the amount of hemoglobin in 100 ml of blood. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. (NCI CTCAE)PMC12328183
anemiaAssociated With?Not AvailableA disorder characterized by a reduction in the amount of hemoglobin in 100 ml of blood. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. (NCI CTCAE)PMC10305463
type 2 diabetes mellitusAssociated With?increaseNot AvailablePMC7230842
osteoporosisIs Biomarker OfNot AvailableA disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. (NCI CTCAE)PMC6372817
osteoporosisAssociated With?increaseA disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. (NCI CTCAE)PMC10049198 , PMC12777449
diabetes mellitusAssociated With?Not AvailableA glucose metabolism disease characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. (DO)PMC4698376
ischemic strokeAssociated With?increaseNot AvailablePMC3730376
ischemic strokeAssociated With?Not AvailableNot AvailablePMC10094154 , PMC11367486
ischemic strokeElevated in Blood InNot AvailableNot AvailablePMC10094154
strokeAssociated With?increaseNot AvailablePMC10051181 , PMC12088975
strokeElevated in Blood InincreaseNot AvailablePMC5020564 , PMC10094154
strokeAssociated With?Not AvailableNot AvailablePMC11679562
strokeElevated in Blood InNot AvailableNot AvailablePMC8638980
chronic painAssociated With?positiveA state in which pain lasts for several weeks or months and may increase in severity.PMC9012384
schizophreniaAssociated With?Not AvailableA psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (DO)PMC10305463
obesityAssociated With?increaseA disorder characterized by having a high amount of body fat. (NCI CTCAE)PMC12564886
atherosclerosisAssociated With?increaseA disorder involving build-up of fatty material and calcium deposition in the arterial wall. It results in partial or complete occlusion of the arterial lumen.PMC10051181 , PMC10049198
atherosclerosisAssociated With?Not AvailableA disorder involving build-up of fatty material and calcium deposition in the arterial wall. It results in partial or complete occlusion of the arterial lumen.PMC5020564 , PMC11413206
atherosclerosisElevated in Blood InNot AvailableA disorder involving build-up of fatty material and calcium deposition in the arterial wall. It results in partial or complete occlusion of the arterial lumen.PMC8638980
hypothyroidismAssociated With?Not AvailableNot AvailablePMC8226782
cardiomyopathyAssociated With?Not AvailableA heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle. (DO)PMC10305463
myocardial infarctionAssociated With?increaseA disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area. (NCI CTCAE)PMC3426376
cognitive impairmentAssociated With?increaseNot AvailablePMC12691759
cognitive impairmentAssociated With?Not AvailableNot AvailablePMC11679562 , PMC13315451
heart diseaseAssociated With?Not AvailableA cardiovascular system disease that involves the heart. (DO)PMC11679562
heart diseaseElevated in Blood InincreaseA cardiovascular system disease that involves the heart. (DO)PMC6396770
placental abruptionAssociated With?increaseNot AvailablePMC11660019
placental abruptionElevated in Urine InNot AvailableNot AvailablePMC9146532
neuropathyAssociated With?Not AvailableA nervous system disease that is located in nerves or nerve cells. (do).PMC8226782
thrombosisAssociated With?increaseA formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system.PMC3460365 , PMC7230842
diseaseAssociated With?Not AvailableNot AvailablePMC8179020
miscarriageElevated in Blood InincreaseA natural death of an embryo or fetus before it is able to survive independently.PMC13409969
miscarriageAssociated With?increaseA natural death of an embryo or fetus before it is able to survive independently.PMC12396911
epilepsyAssociated With?Not AvailableA brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions. (DO)PMC11367486
Parkinson's diseaseAssociated With?Not AvailableA long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time.PMC11367486
vascular diseaseAssociated With?Not AvailableA cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart. (DO)PMC3834880
vascular diseaseElevated in Blood InincreaseA cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart. (DO)PMC10385089
neurodegenerative diseaseAssociated With?Not AvailableA central nervous system disease that results in the progressive deterioration of function or structure of neurons. (DO)PMC12027286
kidney failureAssociated With?Not AvailableNot AvailablePMC8226782
peripheral vascular diseaseAssociated With?Not AvailableA vascular disease that is characterized by obstruction of larger arteries not within the coronary, aortic arch vasculature, or brain. (DO)PMC11679562
Toxic encephalopathyAssociated With?Not AvailableNot AvailablePMC9886801
Toxic encephalopathyAssociated With?increaseNot AvailablePMC12691759
brain edemaAssociated With?increaseNot AvailablePMC9886801
Congenital heart diseaseAssociated With?increaseNot AvailablePMC6210579
migraineAssociated With?increaseA brain disease that is characterized by moderate to severe headaches, nausea, extreme sensitivity to light and sound and intense unilaterial throbbing or pulsing. (DO)PMC12255647
migraineElevated in Blood InincreaseA brain disease that is characterized by moderate to severe headaches, nausea, extreme sensitivity to light and sound and intense unilaterial throbbing or pulsing. (DO)PMC3444221
migraineAssociated With?Not AvailableA brain disease that is characterized by moderate to severe headaches, nausea, extreme sensitivity to light and sound and intense unilaterial throbbing or pulsing. (DO)PMC10008946
vitamin B12 deficiencyElevated in Blood InincreaseA vitamin metabolic disorder that results from low blood levels of vitamin B12. (DO)PMC3834880
vitamin B12 deficiencyIs Biomarker OfNot AvailableA vitamin metabolic disorder that results from low blood levels of vitamin B12. (DO)PMC8419074
brain diseaseAssociated With?Not AvailableNot AvailablePMC10305463
pulmonary hypertensionAssociated With?Not AvailableNot AvailablePMC10305463
hepatic fibrosisAssociated With?Not AvailableNot AvailablePMC13066785
vascular dementiaAssociated With?increaseNot AvailablePMC9414574
post-traumatic stress disorderElevated in Blood InincreaseNot AvailablePMC6930747
vitiligoAssociated With?Not AvailableA hypersensitivity reaction type II disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes. (DO)PMC10590312
Cell DeathAssociated With?decreaseNot AvailablePMC6787199
Oxidative StressAssociated With?Not AvailableNot AvailablePMC11832355 , PMC7761442
Oxidative StressAssociated With?increaseNot AvailablePMC5016891 , PMC11275227
cardiovascular disorderAssociated With?Not AvailableNot AvailablePMC7288538 , PMC7288538
cardiovascular disorderAssociated With?increaseNot AvailablePMC3460365 , PMC6342530
cardiovascular disorderElevated in Blood InNot AvailableNot AvailablePMC8638980
Fetal DeathAssociated With?increaseNot AvailablePMC11660019
Endoplasmic Reticulum StressAssociated With?decreaseNot AvailablePMC9886801
DNA DamageAssociated With?Not AvailableNot AvailablePMC9886801 , PMC7337253
nervous system disorderAssociated With?increaseNot AvailablePMC12027286
metabolic diseaseAssociated With?increaseNot AvailablePMC8638980
Deep venous thrombosisAssociated With?increaseNot AvailablePMC12396911
depressive disorderAssociated With?Not AvailableNot AvailablePMC3506942
Premature birthAssociated With?Not AvailableNot AvailablePMC7278868
Premature birthAssociated With?increaseNot AvailablePMC12396911
Genomic InstabilityAssociated With?increaseNot AvailablePMC8638980
Congenital AbnormalitiesAssociated With?increaseNot AvailablePMC6210579
Congenital AbnormalitiesAssociated With?Not AvailableNot AvailablePMC4698376
hypertension, pregnancy-inducedAssociated With?increaseNot AvailablePMC12396911
NeurodegenerationAssociated With?Not AvailableNot AvailablePMC9886801 , PMC9886801
Mental deteriorationAssociated With?increaseNot AvailablePMC7337253
Mental deteriorationAssociated With?Not AvailableNot AvailablePMC9414574 , PMC9414574
SarcopeniaAssociated With?Not AvailableNot AvailablePMC8226782 , PMC8226782
Neurodegenerative DiseasesAssociated With?Not AvailableNot AvailablePMC4698376
hyperlipidemiaAssociated With?increaseNot AvailablePMC5016891
ThromboembolismAssociated With?Not AvailableNot AvailablePMC10305463
MutationAssociated With?increaseNot AvailablePMC8638980
peripheral arterial diseaseAssociated With?increaseNot AvailablePMC3426376
cognitive disorderAssociated With?Not AvailableNot AvailablePMC3834880
Brain atrophyAssociated With?Not AvailableNot AvailablePMC9414574 , PMC9414574
hyperhomocysteinemiaAssociated With?Not AvailableNot AvailablePMC7414014 , PMC7761442
hyperhomocysteinemiaElevated in Blood InNot AvailableNot AvailablePMC12691759 , PMC13315451
hyperhomocysteinemiaElevated in Blood InincreaseNot AvailablePMC5020564
chronic renal failure syndromeElevated in Blood InNot AvailableNot AvailablePMC5020564
homocystinuriaIs Biomarker OfNot AvailableNot AvailablePMC9544878
homocystinuriaAssociated With?Not AvailableNot AvailablePMC11355204 , PMC11482134
homocystinuria due to methylene tetrahydrofolate reductase deficiencyElevated in Blood InincreaseNot AvailablePMC3460365
autosomal recessive diseaseElevated in Blood InincreaseNot AvailablePMC11355204
Decreased circulating folate concentrationAssociated With?Not AvailableNot AvailablePMC3527168 , PMC8226782
Decreased circulating folate concentrationIs Biomarker OfNot AvailableNot AvailablePMC6701563
carotid stenosisElevated in Blood InincreaseNot AvailablePMC5020564
Neurofibrillary tanglesAssociated With?Not AvailableNot AvailablePMC9414574
musculoskeletal system disorderAssociated With?Not AvailableNot AvailablePMC11659002
acatalasiaElevated in Blood InincreaseNot AvailablePMC3016327
Folic Acid DeficiencyIs Biomarker OfNot AvailableNot AvailablePMC3834880
hemolytic-uremic syndromeAssociated With?Not AvailableNot AvailablePMC10305463
Exposure Sources
Source IDSourceSectorReference
CEDs000010Insecticides?Insecticides are synthetic chemicals designed to control or eliminate insect pests that threaten crops and other agricultural products.Agriculture & land managementPubChem
CEDs000070Stormwater runoff?Stormwater runoff refers to the flow of rainwater or melted snow that does not soak into the ground and instead collects pollutants as it travels over impervious surfaces such as roads and parking lots.Automotive & urban infrastructurePubChem
CEDs000233Brushes?Brushes used in personal care and cosmetics can be a source of synthetic chemical contamination due to the materials and coatings used in their manufacturing.Personal care & cosmeticsPubChem
CEDs000506Antennas?Antennas, commonly used in communication technologies, can be a source of synthetic chemical contamination through the materials and coatings used in their construction.Electrical & Electronic EquipmentPubChem
CEDs000511Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.Electrical & Electronic EquipmentPubChem
CEDs000518Electrically Stimulated Smoking Devices?Electrically stimulated smoking devices, commonly known as e-cigarettes or vape pens, utilize electrical components to heat a liquid solution, often containing nicotine, flavorings, and other additives, to produce an aerosol for inhalation.Electrical & Electronic EquipmentPubChem
CEDs000519Electrodes?Electrodes, used in various electrical and electronic applications, can be a source of synthetic chemical contamination due to the materials from which they are constructed and the processes involved in their manufacturing.Electrical & Electronic EquipmentPubChem
CEDs000524Hybrid Capacitors?Hybrid capacitors are energy storage devices that combine the properties of electrolytic and supercapacitors, utilizing a combination of electrochemical principles to achieve higher energy density and power density.Electrical & Electronic EquipmentPubChem
CEDs000544Fermentation Processes For Beer?Fermentation processes for beer involve the conversion of sugars into alcohol and carbon dioxide by yeast.Food, food processing & cookwarePubChem
CEDs000545Food Preservation?Food preservation often involves the use of synthetic chemicals, such as preservatives, flavor enhancers, and color additives, to extend shelf life and enhance the sensory qualities of food products.Food, food processing & cookwarePubChem
CEDs000555Bleaching Agents?Bleaching agents are chemical substances used to whiten or lighten materials, often employed in various cleaning products for their stain removal and disinfecting properties.Household cleaning & consumer productsPubChem
CEDs000556Cigar Cigarettes?Cigar cigarettes are a source of synthetic chemical contamination due to the combustion of various tobacco blends and additives.Household cleaning & consumer productsPubChem
CEDs000561Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.Household cleaning & consumer productsPubChem
CEDs000563Soap Detergents?Soap detergents are synthetic surfactants designed to enhance the cleaning efficacy of water by reducing surface tension, allowing for better interaction with dirt and grease.Household cleaning & consumer productsPubChem
CEDs000569Tobacco Smoke Filters?Tobacco smoke filters are designed to reduce the inhalation of harmful substances in cigarette smoke, including tar and other particulate matter.Household cleaning & consumer productsPubChem
CEDs000580Manufacture Preparation Of Tobacco Products?The manufacture and preparation of tobacco products involve various processes that can result in the introduction of synthetic chemicals into the environment.Industrial manufacturing & chemical processingPubChem
CEDs000600Herbicides And Algicides?Herbicides and algicides are synthetic chemicals primarily used to control unwanted plants and algae in various environments.Agriculture & land managementPubChem
CEDs000603Nematocides?Nematocides are synthetic chemicals specifically designed to control nematodes, which are microscopic roundworms that can cause significant damage to crops and plants.Agriculture & land managementPubChem
CEDs000605Pest Repellants?Pest repellents, often formulated from synthetic chemicals, are widely used to protect crops from insect infestations and other pests.Agriculture & land managementPubChem
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementPubChem
CEDs000609Aftershave?Aftershave is a grooming product typically used to soothe and protect the skin following shaving.Personal care & cosmeticsPubChem
CEDs000610Aftersun Products?Aftersun products are designed to soothe and hydrate the skin after sun exposure, often containing various synthetic chemicals such as emollients, preservatives, and fragrances.Personal care & cosmeticsPubChem
CEDs000611Anti Perspirants Or Body Deoderants?Antiperspirants and body deodorants commonly contain synthetic chemicals such as aluminum compounds, parabens, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000613Depilatories?Depilatories are products designed to remove unwanted hair through the application of synthetic chemicals that break down the protein structure of hair, facilitating its removal.Personal care & cosmeticsPubChem
CEDs000614Essential Oils Or Perfumes?Essential oils and perfumes are complex mixtures of volatile compounds derived from natural or synthetic sources, commonly used for their aromatic properties.Personal care & cosmeticsPubChem
CEDs000615Eye Makeup Products?Eye makeup products, including mascaras, eyeliners, and eyeshadows, often contain a variety of synthetic chemicals such as pigments, preservatives, and film-forming agents.Personal care & cosmeticsPubChem
CEDs000617Lip Care Products?Lip care products, including lipsticks, balms, and glosses, often contain a variety of synthetic chemicals such as parabens, phthalates, and synthetic fragrances.Personal care & cosmeticsPubChem
CEDs000618Lip Makeup Products?Lip makeup products, such as lipsticks, lip glosses, and lip liners, often contain a variety of synthetic chemicals, including pigments, preservatives, and emollients.Personal care & cosmeticsPubChem
CEDs000632Apparel?Apparel production often involves the use of various synthetic chemicals, including dyes, finishing agents, and preservatives.Textiles, leather & furnishingsPubChem
CEDs000642Footwear?Footwear production often involves the use of various synthetic chemicals, such as adhesives, dyes, and treatments, which can contribute to environmental contamination.Textiles, leather & furnishingsPubChem
CEDs000662Yarns Or Threads?Yarns or threads used in textiles can be a source of synthetic chemical contamination due to the production processes and treatments they undergo.Textiles, leather & furnishingsPubChem
CEDs000671Airplanes And Helicopters?Airplanes and helicopters are significant sources of synthetic chemical contamination primarily through the use of aviation fuels, lubricants, and de-icing agents.Aviation & AerospacePubChem
CEDs000678Nitrogenous Fertilisers?Nitrogenous fertilizers are synthetic chemical compounds primarily used to enhance plant growth by supplying essential nitrogen, a crucial nutrient for photosynthesis and protein synthesis.Agriculture & land managementPubChem
CEDs000679Phosphatic Fertilisers?Phosphatic fertilizers are synthetic chemical products primarily composed of phosphorus, which is essential for plant growth.Agriculture & land managementPubChem
CEDs000684Cements?Cements are a composite material primarily used as a binding agent in construction applications, formed by the calcination of limestone and clay minerals at high temperatures.Building & ConstructionPubChem
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionPubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
CEDs000698Jewellery?Jewellery production often involves the use of various synthetic chemicals during the extraction and processing of metals.Mining & metal processingPubChem
CEDs000730Contact Lens Cases?Contact lens cases are small containers designed to store contact lenses in a sterile environment, typically made from various synthetic materials including plastics such as polypropylene or polycarbonate.Healthcare, pharmaceuticals & veterinary productsPubChem
CEDs000734Coating Compositions?Coating compositions, which include paints, sealants, and varnishes, are formulated with a variety of synthetic chemicals such as solvents, resins, pigments, and additives.Building & ConstructionPubChem
CEDs000735Explosives?Explosives are chemical compounds or mixtures designed to undergo rapid decomposition, releasing energy in the form of gas and heat.Defense & military infrastructurePubChem
CEDs000738Cooling Circuit Water?Cooling circuit water is utilized in various industrial processes to absorb and dissipate heat generated during operations.Industrial manufacturing & chemical processingPubChem
CEDs000739Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.Paper, pulp & fiber productsPubChem
CEDs000740Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.Paper, pulp & fiber productsPubChem
CEDs000741Pigment Pastes?Pigment pastes are concentrated dispersions of pigments used to impart color and properties to materials.Paper, pulp & fiber productsPubChem
CEDs000742Leather Tanning?Leather tanning is a process that transforms raw animal hides into durable leather through the application of various chemicals, including chromium salts, aldehydes, and vegetable tannins.Textiles, leather & furnishingsPubChem
CEDs000743Sludge Treatment?Sludge treatment involves the processing of waste materials generated from wastewater treatment plants, which often contain a variety of organic and inorganic substances.Wastewater, sanitation & biosolidsPubChem
CEDs000744Water, Wastewater, & Sewage Treatment?Water, wastewater, and sewage treatment processes are critical for managing and mitigating pollutants in water systems.Wastewater, sanitation & biosolidsPubChem
CEDs01223Green TeaFood, food processing & cookwarePMC12192211
CEDs02255WaterAquatic systems & sedimentsPMC4976779
CEDs02459Artificial SeawaterAquatic systems & sedimentsPMC10700628
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Cystathionine beta-synthase structureClick to view 3D structureCystathionine beta-synthaseP35520HumansKnownNot Available
Click to view 3D structureMetabotropic glutamate receptor 8P47743Mus musculusPredicted (SEA)
Prediction Confidence Score
0.533
Applicability Domain
0.565
Statistical Significance
2.00e-05
Supporting Reference Compounds
2
E-value
0.155698
Click to view 3D structureAsc-type amino acid transporter 1P63116RatPredicted (SEA)
Prediction Confidence Score
0.5
Applicability Domain
0.5
Statistical Significance
2.00e-05
Supporting Reference Compounds
2
E-value
0.155698
Click to view 3D structureMetabotropic glutamate receptor 6P35349Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.492
Applicability Domain
0.565
Statistical Significance
6.00e-05
Supporting Reference Compounds
24
E-value
0.467095
Click to view 3D structureMetabotropic glutamate receptor 4P31423Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.468
Applicability Domain
0.565
Statistical Significance
2.00e-04
Supporting Reference Compounds
38
E-value
1.55698
Click to view 3D structureMetabotropic glutamate receptor 2P31421Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.468
Applicability Domain
0.565
Statistical Significance
2.30e-04
Supporting Reference Compounds
53
E-value
1.79053
Arginase structureClick to view 3D structureArginaseQ8I384Plasmodium falciparumPredicted (SEA)
Prediction Confidence Score
0.464
Applicability Domain
0.464
Statistical Significance
6.00e-05
Supporting Reference Compounds
1
E-value
0.467095
Click to view 3D structureMetabotropic glutamate receptor 6O15303HumansPredicted (SEA)
Prediction Confidence Score
0.455
Applicability Domain
0.565
Statistical Significance
1.40e-04
Supporting Reference Compounds
39
E-value
1.08989
Metabotropic glutamate receptor 4 structureClick to view 3D structureMetabotropic glutamate receptor 4Q14833HumansPredicted (SEA)
Prediction Confidence Score
0.448
Applicability Domain
0.565
Statistical Significance
6.00e-04
Supporting Reference Compounds
69
E-value
4.67095
Click to view 3D structureMetabotropic glutamate receptor 8P70579Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.443
Applicability Domain
0.565
Statistical Significance
9.00e-05
Supporting Reference Compounds
28
E-value
0.700643
Excitatory amino acid transporter 3 structureClick to view 3D structureExcitatory amino acid transporter 3P43005HumansPredicted (SEA)
Prediction Confidence Score
0.432
Applicability Domain
0.565
Statistical Significance
1.60e-04
Supporting Reference Compounds
13
E-value
1.24559
Metabotropic glutamate receptor 8 structureClick to view 3D structureMetabotropic glutamate receptor 8O00222HumansPredicted (SEA)
Prediction Confidence Score
0.427
Applicability Domain
0.565
Statistical Significance
1.70e-04
Supporting Reference Compounds
48
E-value
1.32344
Glutamate receptor ionotropic, kainate 1 structureClick to view 3D structureGlutamate receptor ionotropic, kainate 1P22756Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.421
Applicability Domain
0.565
Statistical Significance
2.00e-04
Supporting Reference Compounds
45
E-value
1.55698
Methionine synthase structureClick to view 3D structureMethionine synthaseP13009Escherichia coli (strain K12)KnownNot Available
Glutamine synthetase structureClick to view 3D structureGlutamine synthetaseP0A9C5Escherichia coli K-12Predicted (SEA)
Prediction Confidence Score
0.419
Applicability Domain
0.419
Statistical Significance
4.00e-05
Supporting Reference Compounds
1
E-value
0.311397
Click to view 3D structureS-methylmethionine--homocysteine S-methyltransferase BHMT2Q9H2M3HumansPredicted (SEA)
Prediction Confidence Score
0.419
Applicability Domain
0.419
Statistical Significance
5.00e-05
Supporting Reference Compounds
1
E-value
0.389246
Glutamate receptor ionotropic, kainate 1 structureClick to view 3D structureGlutamate receptor ionotropic, kainate 1P39086HumansPredicted (SEA)
Prediction Confidence Score
0.419
Applicability Domain
0.565
Statistical Significance
1.10e-04
Supporting Reference Compounds
31
E-value
0.856341
Arginase-2, mitochondrial structureClick to view 3D structureArginase-2, mitochondrialP78540HumansPredicted (SEA)
Prediction Confidence Score
0.414
Applicability Domain
0.464
Statistical Significance
4.00e-05
Supporting Reference Compounds
7
E-value
0.311397
Glutamate receptor ionotropic, kainate 3 structureClick to view 3D structureGlutamate receptor ionotropic, kainate 3P42264Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.41
Applicability Domain
0.565
Statistical Significance
1.80e-04
Supporting Reference Compounds
26
E-value
1.40129
Glutamate receptor ionotropic, kainate 2 structureClick to view 3D structureGlutamate receptor ionotropic, kainate 2P42260Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.41
Applicability Domain
0.565
Statistical Significance
1.50e-04
Supporting Reference Compounds
18
E-value
1.16774
Metabotropic glutamate receptor 2 structureClick to view 3D structureMetabotropic glutamate receptor 2Q14416HumansPredicted (SEA)
Prediction Confidence Score
0.409
Applicability Domain
0.565
Statistical Significance
7.00e-04
Supporting Reference Compounds
85
E-value
5.44945
Betaine--homocysteine S-methyltransferase 1 structureClick to view 3D structureBetaine--homocysteine S-methyltransferase 1Q93088HumansPredicted (SEA)
Prediction Confidence Score
0.406
Applicability Domain
0.406
Statistical Significance
6.00e-05
Supporting Reference Compounds
1
E-value
0.467095
Glutamate transporter homolog structureClick to view 3D structureGlutamate transporter homologO59010Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 /NBRC 100139 / OT-3)Predicted (SEA)
Prediction Confidence Score
0.4
Applicability Domain
0.478
Statistical Significance
5.00e-05
Supporting Reference Compounds
3
E-value
0.389246
Metabotropic glutamate receptor 1 structureClick to view 3D structureMetabotropic glutamate receptor 1Q13255HumansPredicted (SEA)
Prediction Confidence Score
0.39
Applicability Domain
0.565
Statistical Significance
5.60e-04
Supporting Reference Compounds
68
E-value
4.35956
Glutamate receptor ionotropic, kainate 2 structureClick to view 3D structureGlutamate receptor ionotropic, kainate 2Q13002HumansPredicted (SEA)
Prediction Confidence Score
0.389
Applicability Domain
0.565
Statistical Significance
1.10e-04
Supporting Reference Compounds
16
E-value
0.856341
Metabotropic glutamate receptor 1 structureClick to view 3D structureMetabotropic glutamate receptor 1P23385Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.384
Applicability Domain
0.565
Statistical Significance
4.90e-04
Supporting Reference Compounds
45
E-value
3.81461
Click to view 3D structureGlutamate receptor 4P48058HumansPredicted (SEA)
Prediction Confidence Score
0.384
Applicability Domain
0.565
Statistical Significance
1.10e-04
Supporting Reference Compounds
25
E-value
0.856341
3-mercaptopyruvate sulfurtransferase structureClick to view 3D structure3-mercaptopyruvate sulfurtransferaseP25325HumansKnownNot Available
Albumin structureClick to view 3D structureAlbuminP02768HumansKnownNot Available
Methylenetetrahydrofolate reductase (NADPH) structureClick to view 3D structureMethylenetetrahydrofolate reductase (NADPH)P42898HumansKnownNot Available
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available